A new story about an old guy: Is Alzheimer's disease infectious?

Neurodegenerative Diseases

Volumn 7, Issue 4, 2010, Pages 272-278

  Reis, Helton J ^a   Mukhamedyarov, Marat A ^b   Rizvanov, Albert A ^c   Palotás, András ^d  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^c YEDITEPE UNIVERSITY   (Turkey)

^d Asklepios Med (Private Practice and Research Center)   (Hungary)

Author keywords

Amyloid; Alzheimer's disease; Conformational disease; Infection; Prion

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; PRION PROTEIN;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CELL INCLUSION; CELL VACUOLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CHLAMYDIAL PNEUMONIA; CONFORMATIONAL TRANSITION; CREUTZFELDT JAKOB DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE TRANSMISSION; FATAL FAMILIAL INSOMNIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HEALTH CARE COST; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; KURU; MOLECULAR INTERACTION; MYCOBACTERIUM; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PREVALENCE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; REVIEW; RISK FACTOR; STRUCTURAL HOMOLOGY;

ALZHEIMER DISEASE; ANIMALS; COMMUNICABLE DISEASES; HUMANS;

EID: 77952472643     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000309659     Document Type: Review

References (35)

1. Palotás A, Penke B, Kemény L, Janka Z, Kálmán J: A chapter in the unity of variety - calcium is the sole author? Brain Res 2004; 1000: 57-59.
2. Jellinger KA: Recent advances in our understanding of neurodegeneration. J Neural Transm 2009; 116: 1111-1162.
3. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG: Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 1992; 255: 728-730.
4. Wu J, Anwyl R, Rowan MJ: α-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. Neuroreport 1995; 6: 2409-2413.
5. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW: Neurodegeneration induced by α-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 1993; 13: 1676-1687.
6. Dumery L, Bourdel F, Soussan Y, Fialkowsky A, Viale S, Nicolas P, Reboud-Ravaux M: α- Amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease. Pathol Biol (Paris) 2001; 49: 72-85. (Pubitemid 32174334)
7. Yankner BA, Duffy LK, Kirschner DA: Neurotrophic and neurotoxic effects of amyloid-β protein: reversal by tachykinin neuropeptides. Science 1990; 250: 279-282.
8. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI: The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999; 38: 7609-7616. (Pubitemid 29289332)
9. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VMY, Trojanowski JQ, Iwatsubo T: Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998; 152: 879-884. (Pubitemid 28173348)
10. Ditter SM, Mirra SS: Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987; 37: 754-760.
11. Hansen LA, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M: The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990; 40: 1-8.
12. Galasko D, Hansen L, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ: Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994; 51: 888-895.
13. Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ: Antibodies to α-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 1999; 45: 353-357.
14. Hamilton RL: Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol 2000; 10: 378-384.
15. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE: Purification and structural studies of a major scrapie prion protein. Cell 1984; 38: 127-134.
16. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG: Scrapie prions aggregate to form amyloid- like birefringent rods. Cell 1983; 35: 349-358.
17. Tahiri-Alaoui A, Gill AC, Disterer P, James W: Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to CJD. J Biol Chem 2004; 279: 31390-31397.
18. Berr C, Helbecque N, Sazdovitch V, Mohr M, Amant C, Amouyel P, Alpérovitch A, Hauw JJ: Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing. Acta Neuropathol 2003; 106: 71-74.
19. Esiri MM, Carter J, Ironside JW: Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases. Neuropathol Appl Neurobiol 2000; 26: 273-284.
20. Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ, Ribalta T: Prion protein expression in senile plaques in Alzheimer's disease. Acta Neuropathol 2001; 101: 49-56.
21. Humpel C, Blasko I, Oberbauer H, Lederer W, Walch T, Marksteiner J, Hinterhuber H: Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease: focus on MCP-1 and NGF. J Neurochem 2005; 94(suppl 2):43.
22. Riek R: Cell biology: infectious Alzheimer's disease? Nature 2006; 444: 429-431.
23. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M: Exogenous induction of cerebral α-amyloidogenesis is governed by agent and host. Science 2006; 313: 1781-1784.
24. Palotás A, Kálmán J: Candidate susceptibility genes in Alzheimer's disease are at high risk for being forgotten - they don't give peace of mind' Curr Drug Metab 2006; 7: 273-293.
25. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ: Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 2004; 25: 619-627.
26. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998; 88: 1337-1342.
27. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Penney M, Ritchie D, Ironside JW: Accumulation of prion protein in tonsil and appendix: review of tissue samples. Br Med J 2002; 325: 633-634.
28. Spinney L: vCJD epidemic could be the first of many, experts warn. Nat Med 2003; 9: 1096.
29. Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX, Roth K, Aguzzi A, Staufenbiel M, Walker LC, Jucker M: Induction of cerebral α-amyloidosis: intracerebral versus systemic Aβ inoculation. Proc Natl Acad Sci USA 2009; 106: 12926-12931.
30. de Vries HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J: The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 1996; 64: 37-43.
31. Finke S, Conzelmann KK: Replication strategies of rabies virus. Virus Res 2005; 111: 120-131.
32. Papp H, Pákáski M, Kása P: Presenilin-1 and the amyloid precursor protein are transported bidirectionally in the sciatic nerve of adult rat. Neurochem Int 2002; 41: 429-435.
33. Reis HJ, Mukhamedyarov MA, Rizvanov AA, Palotás A: In the name of science: don't tamper with the deceptive truth' Mini Rev Med Chem 2009; 9: 1676-1677.
34. Gatz M, Fratiglioni L, Johansson B, Berg S, Mortimer JA, Reynolds CA, Fiske A, Pedersen NL: Complete ascertainment of dementia in the Swedish Twin Registry: the Harmony study. Neurobiol Aging 2005; 26: 439-447.
35. Steffens DC, Plassman BL, Helms MJ, Welsh- Bohmer KA, Newman TT, Breitner JC: APOE and AD concordance in twin pairs as predictors of AD in first-degree relatives. Neurology 2000; 54: 593-598.